Search research articles
Contact Us
Filters
Showing results (221-230 of 245) with videos related to
Page
of 25
Sort By:
The Journal of Arthroplasty
|
October 29, 2025
ICM 2025: New Technologies like Artificial Intelligence, Robotics, and Anti-Biofilm
André Grenho, Antea Buterin, Patrick M Pallitto, et al.
Nature Communications
|
October 3, 2023
Uncovering the complex relationship between balding, testosterone and skin cancers in men
Jue-Sheng Ong, Mathias Seviiri, Jean Claude Dusingize, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
JAMA Surgery
|
February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Irene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
International Journal of Cancer
|
September 5, 2018
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility
James S Wilmott, Peter A Johansson, Felicity Newell, et al.
Cancer Cell
|
December 24, 2021
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
Felicity Newell, Ines Pires da Silva, Peter A Johansson, et al.
Cancer Cell
|
February 7, 2025
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
Felicity Newell, Ines Pires da Silva, Peter A Johansson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience
Francis Proulx-Rocray, Rebecca Symons, Yang Wang, et al.
Cancer Immunology Research
|
March 6, 2021
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival
Nicholas A Gherardin, Kelly Waldeck, Alex Caneborg, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 245) with videos related to
Sort By:
Page
of 25
The Journal of Arthroplasty
|
October 29, 2025
ICM 2025: New Technologies like Artificial Intelligence, Robotics, and Anti-Biofilm
André Grenho, Antea Buterin, Patrick M Pallitto, et al.
Nature Communications
|
October 3, 2023
Uncovering the complex relationship between balding, testosterone and skin cancers in men
Jue-Sheng Ong, Mathias Seviiri, Jean Claude Dusingize, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
JAMA Surgery
|
February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Irene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
International Journal of Cancer
|
September 5, 2018
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility
James S Wilmott, Peter A Johansson, Felicity Newell, et al.
Cancer Cell
|
December 24, 2021
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
Felicity Newell, Ines Pires da Silva, Peter A Johansson, et al.
Cancer Cell
|
February 7, 2025
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
Felicity Newell, Ines Pires da Silva, Peter A Johansson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience
Francis Proulx-Rocray, Rebecca Symons, Yang Wang, et al.
Cancer Immunology Research
|
March 6, 2021
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival
Nicholas A Gherardin, Kelly Waldeck, Alex Caneborg, et al.
Page
of 25